← Back to Patent Explorer
US4522814A Expired / Lapsed US ⏱️ 0.0 years remaining

Composition of matter from Cryptosiphonia woodii useful for the treatment of herpes simplex virus

Assignee: Individual
•
Filing: 1982-11-05
•
Granted: 1985-06-11
•
Expires: 2002-11-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A water extract of homogenized Cryptosiphonia woodii is useful for the treatment of herpes simplex viral infections. The active agent in the extract is a polysaccharide containing glucose and galactose. Herpes infections may be treated in subjects, e.g. human patients, by administering to the subject an effective amount of an aqueous extract of C. woodii, particularly a water extract. This treatment method is effective for treating subjects both prior to and subsequent to infection. It may involve topical application to alleviate symptoms associated with herpes infections or desirably may be systemic, e.g. by oral administration, to eradicate the virus and thereby prevent symptom recurrence.

Inventors

  • 👤 Arthur M. Nonomura
  • 👤 Raphael Pappo

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 18:24
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 51 words
A composition of matter useful for the treatment of herpes simplex virus infection in a subject comprising an unbuffered water extract of homogenized Cryptosiphonia woodii wherein the extract contains a polysaccharide comprising glucose and galactose units and more than about 5.0% sulfur by weight based on the weight of the extract.
Claim 2
Dependent Claim 51 words
A composition of matter useful for the treatment of herpes simplex virus infection in a subject comprising an unbuffered water extract of homogenized Cryptosiphonia woodii wherein the extract contains a polysaccharide comprising glucose and galactose units and more than about 5.0% sulfur by weight based on the weight of the extract.
Claim 3
Dependent Claim 30 words
A therapeutic composition useful for the treatment of herpes simplex virus infection in a subject comprising an effective antiviral amount of the composition of claim 1 and a suitable carrier.
Claim 4
Dependent Claim 12 words
A therapeutic composition in accordance with claim 2 adapted for topical application.
Claim 5
Dependent Claim 12 words
A therapeutic composition in accordance with claim 2 adapted for systemic application.
Claim 6
Dependent Claim 20 words
A composition of matter in accordance with claim 1 having a pH in the range from about 4.5 to 5.5.
Claim 7
Independent Claim 56 words
A method of treating a herpes simplex virus infection in a subject comprising administering to said subject an effective antiviral amount of an unbuffered aqueous extract of homogenized Cryptosiphonia woodii wherein the extract contains a polysaccharide comprising glucose and galactose units and more than about 5.0% sulfur by weight based on the weight of the extract.
Claim 8
Independent Claim 56 words
A method of treating a herpes simplex virus infection in a subject comprising administering to said subject an effective antiviral amount of an unbuffered aqueous extract of homogenized Cryptosiphonia woodii wherein the extract contains a polysaccharide comprising glucose and galactose units and more than about 5.0% sulfur by weight based on the weight of the extract.
Claim 9
Dependent Claim 14 words
A method in accordance with claim 6 wherein said subject is a human patient.
Claim 10
Dependent Claim 15 words
A method in accordance with claim 6 wherein the aqueous extract is a water extract.
Claim 11
Dependent Claim 22 words
A method in accordance with claim 8 wherein the water extract has a pH in the range from about 4.5 to 5.5.
Claim 12
Dependent Claim 12 words
A method in accordance with claim 6 wherein the administration is topical.
Claim 13
Dependent Claim 12 words
A method in accordance with claim 6 wherein the administration is systemic.
Claim 14
Dependent Claim 15 words
A method in accordance with claim 6 wherein the administration is effected prior to infection.
Claim 15
Dependent Claim 15 words
A method in accordance with claim 6 wherein the administration is effected subsequent to infection.
Claim 16
Dependent Claim 13 words
A method in accordance with claim 11 wherein the systemic administration is oral.

References Cited (Backward Citations)

US4229440A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-06-10 1988-12-10 1989-06-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-06-10 1992-12-10 1993-06-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-06-10 1996-12-10 1997-06-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag